• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2025

9-13 November 2025

Toronto, Canada

The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, foundations, government, not for profit organizations, non-governmental organizations, the private sector, military and private practice.

Find us at BOOTH #215 where we are sharing a space with Médecins Sans Frontières/Doctors without Borders. We are honoured to host Mulikat Okanlawon, noma survivor and advocate, who will be at our booth to speak about this deeply neglected disease and her experience becoming a global voice for neglected communities.

download dndi @ astmh

Symposia

Townhall on global health at a crossroads: navigating the fallout of US disengagement in 2025

Date: Tuesday, 11 November 2025
Time: 1:45-3:30 PM
Room: Convention Center – Room 718B (Level 7)

Chairs: Jamie Bay Nishi, American Society of Tropical Medicine and Hygiene and David Hamer, Department of Global Health, Boston University School of Public Health

Speakers:

  • Jodie Curtis, Venable LLP
  • David Fidock, Microbiology & Immunology, Columbia University
  • Rebecca Martin, Sabin Vaccine Institute
  • Ally Olutu, Ifakara Health Institute
  • Delali Attiogbe Attipoe, North America Director, DNDi
  • Kashef Ijaz, Carter Center
  • Firdausi Qadri, International Centre for Diarrhoeal Disease Research, Bangladesh
  • Elizabeth Hoffman, ONE
  • Angela Weaver, Hellen Keller International

Sustaining the elimination of visceral leishmaniasis in South Asia

Date: Tuesday, 11 November 2025
Time: 4:00-5:45 PM
Room: Convention Center – Room 714 (Level 7)

Chairs: Mary Wilson, University of Iowa College of Medicine, and Om Prakash Singh, Institute of Science, Banaras Hindu University

Speakers:

  • Kristien Cloots, Institute of Tropical Medicine
  • Nadira Karunaweera, University of Colombo
  • Chrisine Petersen, Ohio State University
  • Richard Poche, Genesis Laboratories Inc
  • Abhay Satoskar, Department of Pathology, Ohio State University
  • Fabiana Alves, NTD Leishmaniasis-Mycetoma Cluster Director, DNDi

Scientific sessions

Clinical tropical medicine: febrile illness diagnosis and epidemiology

Date: Monday, 10 November 2025
Time: 10:45 AM -12:30 PM
Room: Convention Center – Room 713 (Level 7)

An AI-powered smartphone application for universal standardized lateral flow assays interpretation
Presenter: Miguel Luengo Oroz, Spotlab
Authors: Bermejo-Peláez D, Darias O, Pastor L, Dacal E, Valles-Lopez R, Cuadrado D, Alastruey-Izquierdo A, Bohorquez L, Marchiol A, Rodriguez-Dominguez M, Canton R, Rubio J, Rodriguez-Tudela JL, Lugeno Oroz M.

Kinetoplastida and other opportunistic and anaerobic protozoa – Epidemiology (including leishmania and trypanosomes) 

Date: Monday, 10 November
Time: 2:15-4:00 PM
Room: Convention Center – Room 602 (Level 600)

Data quality gaps threaten visceral leishmaniasis elimination efforts in Kenya: Findings from a multi-county assessment 
Presenter: Paul Kibati, Anref Health Africa
Authors: Kibati P, Mwiti D, Ndungu L, Gakuo G, Lowana F, Ouugi J, Kutwah M, Muthoni Kinyeru E, Adera C, Bolo S, Ouma V, Ochol D, Muchangi M, Ofire Ofire M, Omondi WP.

Kinetoplastida and other opportunistic and anaerobic protozoa: diagnosis and new detection tools

Date: Monday, 10 November 2025
Time: 4:30-6:15 PM
Room: Convention Center – Room 602 (Level 6)

AI-powered digital microscopy for enhanced diagnosis and monitoring of visceral leishmaniasis
Presenter: Miguel Luengo Oroz, Spotlab
Authors: Dacal E, Yeshanew A, Lin L, Melkamu R, Bermejo-Peláez D, Yasin J, Vallés-Lopez R, Mossa A, Pastor L, Adane D, Cuadrado D, Alves F, Luengo Oroz M, Cruz I.
Early assessment of antibody decline and treatment discrimination in Chagas patients using the
multicruzi serological multiplex assay

Presenter: Ursula Saade, InfYnity Biomarkers; Swiss Tropical and Public Health Institute
Authors: Saade U, Ramirez JC, de Boer J, Bazán N, Mangone N, Ramadier T, Scandale I, Pottel H, Altcheh J, Chatelain E, Zrein M.

Kinetoplastida and other opportunistic and anaerobic protozoa: genomics, proteomics and metabolomics, molecular therapeutic targets. Treatment drug delivery, drug repurposing and drug discovery

Date: Wednesday, 12 November 2025
Time: 9:15-11:00 AM
Room: Convention Center – Room 801A (Level 8)

Evaluating prescriber preferences for indeterminate Chagas treatments: an international cross-sectional study
Presenter: Rodrigo Ville-Benavides, Hospital Médica Sur
Authors: Ville-Benavides R, Forsyth C, Certo M, Gaspar SH, Hugonnet S, Pinazo MJ.
Diagnosis and treatment of T.b. gambiense HAT patients with fexinidazole and the active search for trypanolysis-positive cases in the DRC from 2020 to 2021
Presenter: Junior Matangila, Head of Disease HAT, DNDi
Authors: Ngolo D, Mbo F, Pyana P, Mwamba Miaka E, Mutombo Kalonji W, Nganzobo Ngima P, Tshowa Tshiyamba J, Fukinsia Mmitwo A, Rashidi Assani S, Bilonda A, Nyembo A, Kavunga Lukula P, Munganga J, Tarral A, Valverde O.

Posters

Date: Tuesday, 11 November 2025
Time: 12:00-1:45 PM
Room: Convention Center – Hall E (Level 8)

A systematic review of the clinical study landscape for eumycetoma, 1990-2024
Presenter: Astrid Erber, Medical University of Vienna
Authors: Erber AC, Dahal P, Bonifaz A, Brack M, Brodersen J, Harriss E, Maguire B, Jeleff M, Nyaoke B, Regensburger S, Srambickal A, Strub-Wourgaft N, Tirado-Sanchez A, Weichselberger T, Fahal AH, Zijlstra EE, Guerin PJ.
Barriers to clinical trial enrollment and retention for patients with Chagas disease in South America and the United States
Presenter: Jen Allport-Anderson, Novartis
Authors: Allport-Anderson J, Pontello M, Chaparro RM, Pinazo MJ, Garcia M, Arantes G, Barreira F, Taylor L, Aponte JC, Hochberg N.

Date: Wednesday, 12 November 2025
Time: 11:00 AM – 12:45 PM
Room: Convention Center – Hall E (level 8)

Strengthening community engagement in the delivery of fexinidazole, a new oral drug against Human African Trypanosomaisis (HAT) in the Democratic Republic of Congo
Presenter: Junior Matangila, Head of Disease HAT, DNDi
Authors: Mbo F, Valverde O, Nyembo A, Ngolo D, Matangila J, Mutombo Kalonji W, Mukendi L, Bulanga C, Mwamba Miaka E.
Mixed methods study addressing barriers to contraception in regions endemic for neglected diseases
Presenter: Léo Persoz, Research Consultant, DNDi
Authors: Persoz L, Cota G, Pinazo MJ, Marchiol A, Galvão D, Blum B, Bolo S, Ouma V, Opanga Y, Alves F.
Health system burden expansion and the urgent need for dengue therapeutics: a nationwide analysis of dengue in Brazil (2014–2024)
Presenter: André Siqueira, Head of Dengue Global Programme, DNDi
Authors: Manoella A, Klauss G, Camila R, Ribeiro I, Siqueira A.

Side event

Driving collaborative R&D for neglected patients amidst a funding crisis

Organized by the Canadian Network for Neglected Tropical Diseases and DNDi

Date: Monday, 10 November 2025
Time: 5:30-8:00 PM
Venue: Malaparte I 350 King St W, Toronto, ON M5V 3X5, Canada

Kindly note that this event is by invitation only. Please secure your ticket to this event with the link below or send an email to Tina Lines at info@cnntd.org

Register here to attend

More information

  • Event website
AI & New Tech Funding Chagas disease Dengue Mycetoma Sleeping sickness Visceral leishmaniasis North America

Other events

Loading...
10-21 November 2025

Belém, Brazil

COP30

6 November 2025, 3:00 PM Nairobi

Online

Bridging the gap between research and policy for NTDs amid a changing funding landscape

4-6 November 2025

Antwerp, Belgium & online

65th ITM Colloquium

2-5 November 2025

João Pessoa, Brazil

MedTrop 2025

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license